Clinical Trial Update: IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating IPA-targeted adoptive immunotherapy versus adult haplo-identical cell infusion for induction in high-risk leukemia; study terminated wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• IPA-targeted adoptive immunotherapy
• adult haplo-identical cell infusion

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2024-02-13